{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:40:30Z","timestamp":1792788030367,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":97,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"European and Developing Countries Clinical Trials Partnership (EDCTP) 2 programme","award":["CSA2018HS-2522-ADAM"],"award-info":[{"award-number":["CSA2018HS-2522-ADAM"]}],"id":[{"id":"https:\/\/ror.org\/031jv9v19","id-type":"ROR","asserted-by":"crossref"}]},{"name":"European and Developing Countries Clinical Trials Partnership (EDCTP) 2 programme","award":["CSA2018HS-2522-ADAM"],"award-info":[{"award-number":["CSA2018HS-2522-ADAM"]}],"id":[{"id":"https:\/\/ror.org\/031jv9v19","id-type":"ROR","asserted-by":"crossref"}]},{"name":"European and Developing Countries Clinical Trials Partnership (EDCTP) 2 programme","award":["CSA2018HS-2522-ADAM"],"award-info":[{"award-number":["CSA2018HS-2522-ADAM"]}],"id":[{"id":"https:\/\/ror.org\/031jv9v19","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Between 2022 and 2023, the Mozambican National Malaria Control Programme developed a locally-tailored implementation strategy for programmatic mass drug administration (pMDA), which was piloted in Chidenguele (Manjacaze District), southern Mozambique. Two rounds of door-to-door pMDA with dihydroartemisinin-piperaquine were conducted, targeting 59,271 individuals in 14,818 households, according to administrative data. Satellite imagery was used to support household enumeration and field navigation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      An evaluation of the pMDA was conducted. Coverage was assessed using programmatic data and a community household survey (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009770 individuals). A quasi-experimental design, using neighboring areas not receiving pMDA as a comparison group, was used to evaluate the impact of the pMDA on clinical malaria incidence during the ensuing 22 months through a controlled interrupted time-series analysis of routine surveillance data, adjusting for covariates.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      According to programmatic data, household availability coverage (households reached\/target households) increased from 59.4% (8,796\/14,818) in the first round to 94.3% (13,972\/14,818) in the second, following optimization of the implementation strategy. Programmatic or contact coverage (individuals treated\/target population) increased from 41.2% (24,437\/59,271) to 69.7% (41,320\/59,271). In the second round, 8% of the target population was not reached, 8.7% were absent during visits, 6.9% were ineligible, and 6.7% refused participation. The household survey showed similar coverages and estimated that 81.6% of respondents (628\/770, 95% CI 78.6\u201384.2) were treated in at least one of the rounds. We found weak evidence of a larger decrease in malaria incidence immediately following the pMDA implementation in the pMDA group versus the comparison group (level change incidence risk ratio [IRR]\u2009=\u20090.66,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.074), and no evidence of a difference in the malaria trend over time between the two groups (trend change IRR\u2009=\u20090.96,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.104).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Although more than 90% of target households and individuals were reached in the second round, achieving the recommended 80% programmatic coverage remained challenging. This target was reached only when considering participation in either of the two rounds, highlighting the importance of conducting multiple rounds. High coverage requires strong community engagement, household revisits and\/or fixed points, and substantial human and logistical resources. Using satellite imagery and triangulating with census data allowed us to estimate denominators, though challenges remain in this process. We found weak evidence of an impact on malaria incidence immediately following the pMDA and no evidence of a difference in the incidence trend over time. Overall, pMDA can be implemented under programmatic conditions, but is resource-intensive and should be reserved for specific contexts alongside other core malaria interventions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-026-28353-6","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T22:54:58Z","timestamp":1783032898000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Implementation, coverage and impact of a programmatic mass drug administration campaign for malaria in southern Mozambique"],"prefix":"10.1186","volume":"26","author":[{"given":"Maria","family":"Tusell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Fuente-Soro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ars\u00e9nio","family":"Nhacolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Mart\u00ed-Soler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Vecchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amancio","family":"Nhangave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Bapu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felimone","family":"Amone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Riley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orc\u00eddio","family":"Chivite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nteruma","family":"Catorze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valencia","family":"Novele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilson","family":"Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Chiposse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfa","family":"Moiane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Gomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odety","family":"Chissico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9rcia","family":"Dimene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Sibindy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baltazar","family":"Candrinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Aide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Guinovart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"28353_CR1","doi-asserted-by":"publisher","DOI":"10.30875\/9789287074560","volume-title":"World Malaria Report 2025","author":"World Health Organization","year":"2025","unstructured":"World Health Organization. World Malaria Report 2025. Geneva: WHO; 2025."},{"key":"28353_CR2","unstructured":"Instituto Nacional de Estat\u00edstica (INE) e ICF. Inqu\u00e9rito Demogr\u00e1fico e de Sa\u00fade em Mo\u00e7ambique 2022\u201323. Maputo, Mo\u00e7ambique e Rockville, Maryland, EUA: INE e ICF. 2024."},{"key":"28353_CR3","doi-asserted-by":"publisher","DOI":"10.30875\/9789287076717","volume-title":"World malaria report 2024","author":"World Health Organization","year":"2024","unstructured":"World Health Organization. World malaria report 2024. Geneva: WHO; 2024."},{"key":"28353_CR4","unstructured":"National Malaria Control Programme Mozambique. Malaria Strategic Plan 2017\u20132022. Ministry of Health Mozambique; 2017. Available from: https:\/\/pdf.usaid.gov\/pdf_docs\/PA00W8CM.pdf. Cited 2024 Jan 23."},{"key":"28353_CR5","unstructured":"World Health Organization. Global technical strategy for malaria 2016\u20132030, 2021 update. Geneva: WHO. 2021. Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/342995."},{"key":"28353_CR6","unstructured":"World Health Organization. WHO guidelines for malaria. Geneva: WHO. 2025. Available from: https:\/\/www.who.int\/publications\/i\/item\/guidelines-for-malaria. Cited 2025 Oct 27."},{"key":"28353_CR7","doi-asserted-by":"publisher","first-page":"106209","DOI":"10.1016\/j.actatropica.2021.106209","volume":"225","author":"J Nadia","year":"2022","unstructured":"Nadia J, Lu F. Historical experiences on mass drug administration for malaria control and elimination, its challenges and China\u2019s experience: a narrative review. Acta Trop. 2022;225:106209.","journal-title":"Acta Trop"},{"key":"28353_CR8","unstructured":"World Health Organization. WHO Guidelines for malaria, Preventive chemotherapies\u2009\u2013\u200914 March 2023, v6.1. Geneva: WHO. 2023."},{"key":"28353_CR9","unstructured":"World Health Organization. Mass drug administration for falciparum malaria: a practical field manual. 2017. Available from: https:\/\/www.who.int\/publications-detail-redirect\/9789241513104.\u00a0Cited 2021 July 1."},{"issue":"1","key":"28353_CR10","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12936-019-2832-9","volume":"6","author":"P Aide","year":"2019","unstructured":"Aide P, Candrinho B, Galatas B, Munguambe K, Guinovart C, Luis F, et al. Setting the scene and generating evidence for malaria elimination in Southern Mozambique. Malar J. 2019;6(1):190.","journal-title":"Malar J"},{"issue":"8","key":"28353_CR11","doi-asserted-by":"publisher","first-page":"e1003227","DOI":"10.1371\/journal.pmed.1003227","volume":"17","author":"B Galatas","year":"2020","unstructured":"Galatas B, Sa\u00fate F, Mart\u00ed-Soler H, Guinovart C, Nhamussua L, Simone W, et al. A multiphase program for malaria elimination in southern Mozambique (the Magude project): A before-after study. PLoS Med. 2020;17(8):e1003227.","journal-title":"PLoS Med"},{"key":"28353_CR12","doi-asserted-by":"crossref","unstructured":"Fuente-Soro L, Tusell M, Vecchio J, Nhangave A, Bapu K, Riley C, et al. Operational performance of a programmatic mass drug administration campaign for malaria in southern Mozambique: a comprehensive mixed-methods evaluation of implementation outcomes. BMC Public Health. 2026;26(1):1602.","DOI":"10.1186\/s12889-026-27035-7"},{"key":"28353_CR13","unstructured":"Rep\u00fablica de Mo\u00e7ambique Minist\u00e9rio de Administra\u00e7\u00e3o Estatal. Perfil do Distrito de Mandlakaze Provincia de Gaza. 2005. Maputo, Mo\u00e7ambique"},{"issue":"1Suppl","key":"28353_CR14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.4269\/ajtmh.23-0443","volume":"112","author":"AS Stratil","year":"2025","unstructured":"Stratil AS, Rodrigues M, Armando S, Gomane S, Mussa K, Candrinho B, et al. Optimizing the Delivery of Routine Malaria Data Quality Assessments: A Two-Level Logistic Regression Model to Inform an Institutionalized Approach in Mozambique. Am J Trop Med Hyg. 2025;112(1Suppl):48\u201354.","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"28353_CR15","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"key":"28353_CR16","unstructured":"StataCorp. Stata Statistical Software: Release 18. TX: StataCorp LLC; 2023. Available from: https:\/\/www.stata.com\/."},{"issue":"2","key":"28353_CR17","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1177\/1536867X1501500208","volume":"15","author":"A Linden","year":"2015","unstructured":"Linden A. Conducting Interrupted Time-series Analysis for Single- and Multiple-group Comparisons. Stata J. 2015;15(2):480\u2013500.","journal-title":"Stata J"},{"key":"28353_CR18","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing; 2024. Available from: https:\/\/www.r-project.org\/. Cited 2025 Oct 22."},{"issue":"10","key":"28353_CR19","doi-asserted-by":"publisher","first-page":"e0272655","DOI":"10.1371\/journal.pone.0272655","volume":"17","author":"L Fern\u00e1ndez Montoya","year":"2022","unstructured":"Fern\u00e1ndez Montoya L, M\u00e1quina M, Mart\u00ed-Soler H, Sherrard-Smith E, Alafo C, Opiyo M, et al. The realized efficacy of indoor residual spraying campaigns falls quickly below the recommended WHO threshold when coverage, pace of spraying and residual efficacy on different wall types are considered. PLoS ONE. 2022;17(10):e0272655.","journal-title":"PLoS ONE"},{"key":"28353_CR20","unstructured":"Hufkens K, Labs B, MODISTools. Interface to the \u2018MODIS Land Products Subsets\u2019 Web Services. 2023. Available from: https:\/\/cran.r-project.org\/web\/packages\/MODISTools\/index.html. Cited 2025 Oct 2."},{"key":"28353_CR21","unstructured":"Visual Crossing. Total Weather Data. 2025. Available from: https:\/\/www.visualcrossing.com\/weather-data\/. Cited 2025 Oct 22."},{"issue":"5","key":"28353_CR22","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1080\/03610910701539617","volume":"36","author":"JJ Cui","year":"2007","unstructured":"Cui JJ, Qian G. Selection of working correlation structure and best model in GEE analyses of longitudinal data. Commun Stat Simul Comput. 2007;36(5):987\u201396.","journal-title":"Commun Stat Simul Comput"},{"issue":"8","key":"28353_CR23","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1093\/infdis\/jiaa434","volume":"225","author":"M Fraser","year":"2022","unstructured":"Fraser M, Miller JM, Silumbe K, Hainsworth M, Mudenda M, Hamainza B, et al. Evaluating the Impact of Programmatic Mass Drug Administration for Malaria in Zambia Using Routine Incidence Data. J Infect Dis. 2022;225(8):1415\u201323.","journal-title":"J Infect Dis"},{"issue":"2Suppl","key":"28353_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4269\/ajtmh.19-0665","volume":"103","author":"TP Finn","year":"2020","unstructured":"Finn TP, Yukich JO, Bennett A, Porter TR, Lungu C, Hamainza B, et al. Treatment Coverage Estimation for Mass Drug Administration for Malaria with Dihydroartemisinin\u2013Piperaquine in Southern Province, Zambia. Am J Trop Med Hyg. 2020;103(2Suppl):19\u201327.","journal-title":"Am J Trop Med Hyg"},{"issue":"2Suppl","key":"28353_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4269\/ajtmh.19-0659","volume":"103","author":"TP Eisele","year":"2020","unstructured":"Eisele TP, Bennett A, Silumbe K, Finn TP, Porter TR, Chalwe V, et al. Impact of Four Rounds of Mass Drug Administration with Dihydroartemisinin\u2013Piperaquine Implemented in Southern Province, Zambia. Am J Trop Med Hyg. 2020;103(2Suppl):7\u201318.","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"28353_CR26","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1093\/cid\/ciy196","volume":"67","author":"R Tripura","year":"2018","unstructured":"Tripura R, Peto TJ, Chea N, Chan D, Mukaka M, Sirithiranont P, et al. A Controlled Trial of Mass Drug Administration to Interrupt Transmission of Multidrug-Resistant Falciparum Malaria in Cambodian Villages. Clin Infect Dis. 2018;67(6):817\u201326.","journal-title":"Clin Infect Dis"},{"key":"28353_CR27","doi-asserted-by":"publisher","first-page":"81","DOI":"10.12688\/wellcomeopenres.12240.1","volume":"2","author":"J Landier","year":"2017","unstructured":"Landier J, Kajeechiwa L, Thwin MM, Parker DM, Chaumeau V, Wiladphaingern J, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017;2:81.","journal-title":"Wellcome Open Res"},{"issue":"4Suppl","key":"28353_CR28","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4269\/ajtmh.22-0767","volume":"110","author":"ZD Schneider","year":"2024","unstructured":"Schneider ZD, Busbee AL, Boily MC, Shah MP, Hwang J, Lindblade KA, et al. Mass Drug Administration: Contextual Factor Considerations. Am J Trop Med Hyg. 2024;110(4Suppl):30\u20137.","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"28353_CR29","doi-asserted-by":"publisher","first-page":"e0249080","DOI":"10.1371\/journal.pone.0249080","volume":"16","author":"B Galatas","year":"2021","unstructured":"Galatas B, Nhantumbo H, Soares R, Djive H, Murato I, Simone W et al. LH <>Carvalho editor 2021 Community acceptability to antimalarial mass drug administrations in Magude district, Southern Mozambique: A mixed methods study. PLoS ONE 16 3 e0249080.","journal-title":"PLoS ONE"},{"issue":"2","key":"28353_CR30","doi-asserted-by":"publisher","first-page":"020413","DOI":"10.7189\/jogh.10.020413","volume":"10","author":"J Nice","year":"2020","unstructured":"Nice J, Nahusenay H, Eckert E, Eisele TP, Ashton RA. Estimating malaria chemoprevention and vector control coverage using program and campaign data: A scoping review of current practices and opportunities. J Glob Health. 2020;10(2):020413.","journal-title":"J Glob Health"},{"issue":"suppl1","key":"28353_CR31","doi-asserted-by":"publisher","first-page":"S102","DOI":"10.1093\/infdis\/jiu010","volume":"210","author":"I Barau","year":"2014","unstructured":"Barau I, Zubairu M, Mwanza MN, Seaman VY. Improving Polio Vaccination Coverage in Nigeria Through the Use of Geographic Information System Technology. J Infect Dis. 2014;210(suppl1):S102\u201310.","journal-title":"J Infect Dis"},{"issue":"1","key":"28353_CR32","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s12936-015-0831-z","volume":"14","author":"A Kamanga","year":"2015","unstructured":"Kamanga A, Renn S, Pollard D, Bridges DJ, Chirwa B, Pinchoff J, et al. Open-source satellite enumeration to map households: planning and targeting indoor residual spraying for malaria. Malar J. 2015;14(1):345.","journal-title":"Malar J"},{"issue":"1","key":"28353_CR33","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12936-018-2236-2","volume":"17","author":"DJ Bridges","year":"2018","unstructured":"Bridges DJ, Pollard D, Winters AM, Winters B, Sikaala C, Renn S, et al. Accuracy and impact of spatial aids based upon satellite enumeration to improve indoor residual spraying spatial coverage. Malar J. 2018;17(1):93.","journal-title":"Malar J"},{"issue":"11","key":"28353_CR34","doi-asserted-by":"publisher","first-page":"4849","DOI":"10.1002\/joc.8120","volume":"43","author":"AJ Manhique","year":"2023","unstructured":"Manhique AJ, Reason CJC, Barimalala R. Rainfall onset and cessation over Mozambique and relationship with sea surface temperature and atmospheric patterns. Int J Climatol. 2023;43(11):4849\u201363.","journal-title":"Int J Climatol"},{"key":"28353_CR35","unstructured":"United Nations Office for the Coordination of Humanitarian Affairs. Southern Africa: Snapshot of Tropical Cyclone Freddy\u2019s Impact (February - March 2023). Geneva: OCHA; 2023. Available from: https:\/\/www.unocha.org\/publications\/report\/malawi\/southern-africa-snapshot-tropical-cyclone-freddys-impact-february-march-2023. Cited 2024 Apr 10."},{"issue":"7","key":"28353_CR36","doi-asserted-by":"publisher","first-page":"e680","DOI":"10.1016\/S2214-109X(17)30220-6","volume":"5","author":"OJ Brady","year":"2017","unstructured":"Brady OJ, Slater HC, Pemberton-Ross P, Wenger E, Maude RJ, Ghani AC, et al. Role of mass drug administration in elimination of Plasmodium falciparum malaria: a consensus modelling study. Lancet Global Health. 2017;5(7):e680\u20137.","journal-title":"Lancet Global Health"},{"issue":"1","key":"28353_CR37","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1186\/s12913-022-08080-5","volume":"22","author":"MC Gwayi-Chore","year":"2022","unstructured":"Gwayi-Chore MC, Aruldas K, Avokpaho E, Chirambo CM, Kaliappan SP, Houngb\u00e9gnon P, et al. Defining optimal implementation packages for delivering community-wide mass drug administration for soil-transmitted helminths with high coverage. BMC Health Serv Res. 2022;22(1):792.","journal-title":"BMC Health Serv Res"},{"issue":"12","key":"28353_CR38","doi-asserted-by":"publisher","first-page":"e010321","DOI":"10.1136\/bmjgh-2022-010321","volume":"7","author":"E Bazant","year":"2022","unstructured":"Bazant E, McPhillips-Tangum C, Shrestha SD, Khera GSP, Nic Lochlainn A. Promising practices for the collaborative planning of integrated health campaigns from a synthesis of case studies. BMJ Glob Health. 2022;7(12):e010321.","journal-title":"BMJ Glob Health"},{"issue":"2","key":"28353_CR39","doi-asserted-by":"publisher","first-page":"e0006211","DOI":"10.1371\/journal.pntd.0006211","volume":"12","author":"KV Deardorff","year":"2018","unstructured":"Deardorff KV, Rubin Means A, \u00c1sbj\u00f6rnsd\u00f3ttir KH, Walson J. Strategies to improve treatment coverage in community-based public health programs: A systematic review of the literature. Pullan RL, editor. PLoS Negl Trop Dis. 2018;12(2):e0006211.","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"28353_CR40","doi-asserted-by":"publisher","first-page":"650","DOI":"10.4269\/ajtmh.2006.75.650","volume":"75","author":"BG Blackburn","year":"2006","unstructured":"Blackburn BG, Eigege A, Gotau H, Gerlong G, Miri E, Hawley WA, et al. Successful integration of insecticide-treated bed net distribution with mass drug administration in Central Nigeria. Am J Trop Med Hyg. 2006;75(4):650\u20135.","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"28353_CR41","doi-asserted-by":"publisher","first-page":"505","DOI":"10.4269\/ajtmh.15-0724","volume":"95","author":"UJ Mwingira","year":"2016","unstructured":"Mwingira UJ, Means AR, Chikawe M, Kilembe B, Lyimo D, Crowley K, et al. Integrating Neglected Tropical Disease and Immunization Programs: The Experiences of the Tanzanian Ministry of Health. Am J Trop Med Hyg. 2016;95(3):505\u20137.","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"28353_CR42","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1186\/s12936-023-04784-z","volume":"22","author":"MO Afolabi","year":"2023","unstructured":"Afolabi MO, Sow D, Agbla SC, Fall EHB, Sall FB, Seck A, et al. Feasibility and safety of integrating mass drug administration for helminth control with seasonal malaria chemoprevention among Senegalese children: a randomized controlled, observer-blind trial. Malar J. 2023;22(1):348.","journal-title":"Malar J"},{"issue":"Suppl 4","key":"28353_CR43","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4269\/ajtmh.22-0766","volume":"110","author":"ZD Schneider","year":"2024","unstructured":"Schneider ZD, Shah MP, Boily MC, Busbee AL, Hwang J, Lindblade KA, et al. Mass Drug Administration to Reduce Malaria Transmission: A Systematic Review and Meta-Analysis. Am J Trop Med Hyg. 2024;110(Suppl 4):17\u201329.","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"28353_CR44","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12916-020-01593-y","volume":"18","author":"VA Alegana","year":"2020","unstructured":"Alegana VA, Okiro EA, Snow RW. Routine data for malaria morbidity estimation in Africa: challenges and prospects. BMC Med. 2020;18(1):121.","journal-title":"BMC Med"},{"issue":"3 Suppl","key":"28353_CR45","doi-asserted-by":"publisher","first-page":"46","DOI":"10.4269\/ajtmh.16-0734","volume":"97","author":"RA Ashton","year":"2017","unstructured":"Ashton RA, Bennett A, Yukich J, Bhattarai A, Keating J, Eisele TP. Methodological Considerations for Use of Routine Health Information System Data to Evaluate Malaria Program Impact in an Era of Declining Malaria Transmission. Am J Trop Med Hyg. 2017;97(3 Suppl):46\u201357.","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"28353_CR46","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1186\/s12936-023-04799-6","volume":"22","author":"M Ronald","year":"2023","unstructured":"Ronald M, Humphrey W, Adoke Y, Jean-Pierre VG. Impact of population based indoor residual spraying in combination with mass drug administration on malaria incidence and test positivity in a high transmission setting in north eastern Uganda. Malar J. 2023;22(1):378.","journal-title":"Malar J"},{"issue":"1","key":"28353_CR47","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12916-018-1202-8","volume":"16","author":"U Morris","year":"2018","unstructured":"Morris U, Msellem MI, Mkali H, Islam A, Aydin-Schmidt B, Jovel I, et al. A cluster randomised controlled trial of two rounds of mass drug administration in Zanzibar, a malaria pre-elimination setting-high coverage and safety, but no significant impact on transmission. BMC Med. 2018;16(1):215.","journal-title":"BMC Med"},{"issue":"1","key":"28353_CR48","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1186\/s12936-016-1493-1","volume":"15","author":"M Aregawi","year":"2016","unstructured":"Aregawi M, Smith SJ, Sillah-Kanu M, Seppeh J, Kamara ARY, Williams RO, et al. Impact of the Mass Drug Administration for malaria in response to the Ebola outbreak in Sierra Leone. Malar J. 2016;15(1):480.","journal-title":"Malar J"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-026-28353-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-28353-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-28353-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:37:49Z","timestamp":1791412669000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-026-28353-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["28353"],"URL":"https:\/\/doi.org\/10.1186\/s12889-026-28353-6","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"15 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The pMDA was implemented programmatically under the leadership of the NMCP under an administrative authorization from the Ministry of Health, thus written informed consent was not obtained. However, as with other health activities at the community level, individuals were able to decide whether they accepted to participate or not, and oral consent was sought by the implementation team and registered in the electronic questionnaire at the moment of the visit.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"2861"}}